ESR1 and ductal breast carcinoma in situ: For all four ER+ models, DCIS lesions grew significantly faster in the estrogen-supplemented mice than in the ovariectomized mice, indicating that the DCIS-MIND models retained their estrogen sensitivity (Figures 6I and S6D–S6G).